× Medicines Discovery Catapult

It can take 10-15 years to develop a new medicine at an estimated cost of £1.2bn

At the Medicines Discovery Catapult we aim to help UK SME biotechs, academics and innovators have access to the laboratory facilities, knowledge, data, technologies and networks they need to be able to progress their programmes of medicines research and development. Our objective is to work collaboratively as part of a Syndicate to bring new proven therapies to patients faster and more cost-effectively.

Latest News

Psychiatry Consortium brings Charles River Laboratories and Evotec on board

World-leading drug discovery organisations Charles River Laboratories and Evotec join the Psychiatry Consortium as drug discovery and development partners. The two organisations bring invaluable expertise

LUNAC Therapeutics led project awarded £3.14 million under Innovate UK Biomedical Catalyst programme, to develop next-generation anticoagulant

Today (2nd December 2019) LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the identification and development of advanced anticoagulants with minimal bleeding

Medicines Discovery Catapult finalist for the Bionow Technical Service Award

Yesterday (28th November 2019) Medicines Discovery Catapult (MDC) was recognised at the Bionow Annual Awards 2019, being a finalist for the Bionow Technical Service Award

All News >